A Randomized Phase II/III Trial of De-Intensified Radiation Therapy for Patients with Early-Stage, P16-Positive, Non-Smoking Associated Oropharyngeal Cancer
HN005 is temporarily closed to accrual effective November 8, 2023, at 5pm ET.
Open to Phase II enrollment
